Engineers Gate Manager’s Crescent Biopharma CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$418K Buy
+28,640
New +$480K 0.01% 1637

Other funds holding CBIO

Engineers Gate Manager's CBIO Position: Q3 2026 in Review

Engineers Gate Manager opened a new position in Crescent Biopharma (CBIO) in Q3 2026: 28,640 shares worth $418K. The stake represents 0.01% of the portfolio and ranks #1637 among its holdings.

104 funds tracked by Wall St. Rank hold CBIO as of Q3 2026.

  • Engineers Gate Manager held 28,640 shares of Crescent Biopharma worth $418K as of Q3 2026.
  • Crescent Biopharma was a new Engineers Gate Manager position in Q3 2026.
  • Crescent Biopharma made up 0.01% of Engineers Gate Manager's portfolio in Q3 2026, its #1637 holding.
  • 104 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2026.

Based on Engineers Gate Manager's 13F filing for Q3 2026, filed 16 Nov 2026.